Effectiveness of gentamicin for gonorrhoea treatment: Systematic review and meta-analysis

Postgraduate Medical Journal

Volumn 89, Issue 1049, 2013, Pages 142-147

  Dowell, Deborah ^a   Kirkcaldy, Robert D ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; GENTAMICIN;

ARTICLE; DRUG EFFICACY; DYSURIA; FOLLOW UP; GONORRHEA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; META ANALYSIS; NEPHROTOXICITY; OTOTOXICITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; TREATMENT OUTCOME; URETHRAL DISCHARGE; URETHRITIS; UROGENITAL TRACT DISEASE;

EID: 84877265507     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2012-050604rep     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention (CDC). Cephalosporin susceptibility among Neisseria gonorrhoeae isolates-United States, 2000-2010. MMWR Morb Mortal Wkly Rep 2011;60:873-7.
2. Ito M, Yasuda M, Yokoi S, et al. Remarkable increase in Central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004;48:3185-7.
3. European Centre for Disease Control and Prevention. Gonococcal antimicrobial susceptibility surveillance in Europe-2010. Stockholm: ECDC, 2012.
4. Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010. Eurosurveillance 2010;15:pii:19721.
5. Ison C, Hussey J, Sankar K, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010. Eurosurveillance 2011;16:pii:19833.
6. Unemo M, Golparian D, Stary A, et al. First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Eurosurveillance 2011;16:pii:19998
7. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012;56:1273-80.
8. Brown LB, Krysiak R, Kamanga G, et al. Neisseria gonorrhoeae antimicrobial susceptibility in Lilongwe, Malawi, 2007. Sex Transm Dis 2010;37:169-72.
9. Clinicaltrials.gov. http://www.clinicaltrials.gov/ (accessed 19 Jan 2011).
10. CenterWatch. http://www.centerwatch.com (accessed 19 Jan 2011).
11. Current Controlled Trials. http://www.controlled-trials.com (accessed 19 Jan 2011).
12. World Health Organization International Clinical Trials Registry Platform. http://www.who.int/ictrp/en (accessed 19 Jan 2011).
13. Newman L, Moran J, Workowski K. Update on the management of gonorrhea in adults in the United States. Clin Infect Dis 2007;44(Suppl. 3):S84-101.
14. Lule G, Behets FM-T, Hoffman IF, et al. STD/HIV control in Malawi and the search for affordable and effective urethritis therapy: a first field evaluation. Genitourin Med 1994;70:384-8.
15. Daly CC, Hoffman I, Hobbs M, et al. Development of an antimicrobial susceptibility surveillance system for Neisseria gonorrhoeae in Malawi: comparison of methods. J Clin Microbiol 1997;35:2985-8.
16. Hira SK, Attili VR, Kamanga J, et al. Efficacy of gentamicin and kanamycin in the treatment of uncomplicated gonococcal urethritis in Zambia. Sex Transm Dis 1985;12:52-4.
17. Hantschke D, Strauss P, Linzenmeier G, et al. Treatment of gonorrhoea with single injections of gentamicin. Br J Vener Dis 1973;49:62-4.
18. Tan NJ, Rajan VS, Pang R, et al. Gentamicin in the treatment of infections due to penicillinase-producing gonococci. Br J Vener Dis 1980;56:394-6.
19. Bartunek J, Kraft D, Meyer-Hausner E. Einmal-Behandlung der Gonorrhoe bei Frauen mit Gentamycin (in German). Der Hautarzt 1974;25:622-34.
20. Bowie W, Ronald AR, Krywulak W, et al. Gentamicin in the treatment of gonorrhea in females. Brit J Vener Dis 1974;50:208-11.
21. Hantschke D, Heller W, Straus P, et al. Einmalige sulmycin (gentamycin)-behandlung der gonorrhoe (in German). Der Hautarzt 1973;24:30-3.
22. Hantschke D, Mauss J. (Gonorrhoe-behandlung mit sulmyicn) (in German). Z Haut-Geschl Kr 1970;45:407-12.
23. Bukharovich MN, Revunov VP. (Combined etiological and pathogenetic therapy of urogenital Ureaplasma-Chlamydia-gonococcal infection in men) (in Russian). Antibiot Khimioter 1991;36:39-41.
24. Price MA, Zimba D, Hoffman IF, et al. Addition of treatment for trichomoniasis to syndromic management of urethritis in Malawi: a randomized clinical trial. Sex Transm Dis 2003;30:516-22.
25. Vakulenko S, Mobashery S. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 2003;16:430-50.
26. Vakulenko S, Mobashery S. Versatility of aminoglycosides and prospects for their future. Clin Microbiol Rev 2003;16:430-50.
27. Barclay ML, Begg EJ. Aminoglycoside toxicity and relation to dose regimen. Adverse Drug React Toxicol Rev 1994;13:207-34.
28. Jackson GG, Arcieri G. Ototoxicity of gentamicin in man: a survey and controlled analysis of clinical experience in the United States. J Infect Dis 1971;124:S130-7.
29. Felarca AB, Laqui EM, Ibarra LM. Gentamicin in gonococcal urethritis of Filipino males: dosage and response. J Infect Dis 1971;124:S287-92.
30. Moran JS, Levine WC. Drugs of choice for the treatment of uncomplicated gonococcal infections. Clin Infect Dis 1995;20(Suppl 1):S47-65.
31. Cavenee MR, Farris JR, Spalding TR, et al. Treatment of gonorrhea in pregnancy. Obstet Gynecol 1993;81:33-8.